Allan L. Goldstein
Founder bei REGENERX BIOPHARMACEUTICALS, INC.
Vermögen: 16 $ am 31.03.2024
Profil
Allan L.
Goldstein is the founder of RegeneRx Biopharmaceuticals, Inc. (founded in 1982) where he holds the title of Chairman & Chief Scientific Officer.
He is currently working at George Washington University School of Medicine & Health as a Professor since 1978.
Dr. Goldstein has held former positions as a Trustee at Albert B.
Sabin Vaccine Institute, Inc. (2000-2012), a Principal at The University of Texas at Austin (1972-1978), a Trustee at The Richard B.
& Lynne V.
Cheney Cardiovascular Institute (2006-2012), and a Principal at Albert Einstein College of Medicine, Inc. (1964-1972).
Dr. Goldstein's education includes a graduate and doctorate degree from Rutgers State University of New Jersey and an undergraduate degree from Wagner College (New York) obtained in 1959.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.06.2023 | 16 015 ( 1,07% ) | 16 $ | 31.03.2024 |
Aktive Positionen von Allan L. Goldstein
| Unternehmen | Position | Beginn |
|---|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Founder | 13.05.1982 |
| George Washington University School of Medicine & Health | Corporate Officer/Principal | 01.01.1978 |
Ehemalige bekannte Positionen von Allan L. Goldstein
| Unternehmen | Position | Ende |
|---|---|---|
Albert B. Sabin Vaccine Institute, Inc.
 Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Director/Board Member | 01.01.2012 |
| The Richard B. & Lynne V. Cheney Cardiovascular Institute | Director/Board Member | 01.01.2012 |
| The University of Texas at Austin | Corporate Officer/Principal | 01.01.1978 |
| Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | 01.01.1972 |
Ausbildung von Allan L. Goldstein
| Rutgers State University of New Jersey | Doctorate Degree |
| Wagner College (New York) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Commercial Services |
| The Richard B. & Lynne V. Cheney Cardiovascular Institute |
